129 related articles for article (PubMed ID: 26441207)
1. Prognostic significance of the EGFR pathway in nasopharyngeal carcinoma: a systematic review and meta-analysis.
Ooft ML; Braunius WW; Heus P; Stegeman I; van Diest PJ; Grolman W; Zuur CI; Willems SM
Biomark Med; 2015; 9(10):997-1010. PubMed ID: 26441207
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of EGFR and p-EGFR in nasopharyngeal carcinoma: A systematic review and meta-analysis.
Hong X; Wang G; Xu G; Shi W; Wang T; Rong Z; Mo C
Medicine (Baltimore); 2022 Jan; 101(3):e28507. PubMed ID: 35060503
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor could play a prognostic role to predict the outcome of nasopharyngeal carcinoma: A meta-analysis.
Ma X; Huang J; Wu X; Li X; Zhang J; Xue L; Li P; Liu L
Cancer Biomark; 2014; 14(4):267-77. PubMed ID: 24934370
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of epidermal growth factor receptor in nasopharyngeal carcinoma: a meta-analysis.
Sun W; Long G; Wang J; Mei Q; Liu D; Hu G
Head Neck; 2014 Oct; 36(10):1508-16. PubMed ID: 23996630
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma.
Pan J; Tang T; Xu L; Lu JJ; Lin S; Qiu S; Chen G; K Tham IW
Head Neck; 2013 Sep; 35(9):1238-47. PubMed ID: 22972415
[TBL] [Abstract][Full Text] [Related]
6. SPINK6 Promotes Metastasis of Nasopharyngeal Carcinoma via Binding and Activation of Epithelial Growth Factor Receptor.
Zheng LS; Yang JP; Cao Y; Peng LX; Sun R; Xie P; Wang MY; Meng DF; Luo DH; Zou X; Chen MY; Mai HQ; Guo L; Guo X; Shao JY; Huang BJ; Zhang W; Qian CN
Cancer Res; 2017 Jan; 77(2):579-589. PubMed ID: 27671677
[TBL] [Abstract][Full Text] [Related]
7. Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS.
He F; Wei L; Luo W; Liao Z; Li B; Zhou X; Xiao X; You J; Chen Y; Zheng S; Li P; Murata M; Huang G; Zhang Z
Oncotarget; 2016 Jun; 7(24):37000-37012. PubMed ID: 27203742
[TBL] [Abstract][Full Text] [Related]
8. CDC42-interacting protein 4 promotes metastasis of nasopharyngeal carcinoma by mediating invadopodia formation and activating EGFR signaling.
Meng DF; Xie P; Peng LX; Sun R; Luo DH; Chen QY; Lv X; Wang L; Chen MY; Mai HQ; Guo L; Guo X; Zheng LS; Cao L; Yang JP; Wang MY; Mei Y; Qiang YY; Zhang ZM; Yun JP; Huang BJ; Qian CN
J Exp Clin Cancer Res; 2017 Jan; 36(1):21. PubMed ID: 28129778
[TBL] [Abstract][Full Text] [Related]
9. Apigenin enhances the antitumor effects of cetuximab in nasopharyngeal carcinoma by inhibiting EGFR signaling.
Hu WJ; Liu J; Zhong LK; Wang J
Biomed Pharmacother; 2018 Jun; 102():681-688. PubMed ID: 29604587
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of matrix metalloproteinase 9 in nasopharyngeal carcinoma: a meta-analysis.
Liao D; Huang H; Zhu Z; Li T; Li H; Huang GL; He Z
Minerva Med; 2016 Feb; 107(1):54-61. PubMed ID: 26799856
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of primary gross tumor volume and standardized uptake value of
Jin YN; Yao JJ; Wang SY; Zhang WJ; Zhou GQ; Zhang F; Cheng ZB; Ma J; Mo HY; Sun Y
Tumour Biol; 2017 Jul; 39(7):1010428317717843. PubMed ID: 28671052
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of expression of VEGF and Cox-2 in nasopharyngeal carcinoma and its association with expression of C-erbB2 and EGFR.
Kim TJ; Lee YS; Kang JH; Kim YS; Kang CS
J Surg Oncol; 2011 Jan; 103(1):46-52. PubMed ID: 21031415
[TBL] [Abstract][Full Text] [Related]
13. [Targeted degradation of epidermal growth factor receptor in nasopharyngeal carcinoma by chimeric molecule].
Dong J; Li S; Wang Q; Xiao W; Yin SC
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(4):297-300. PubMed ID: 29871246
[No Abstract] [Full Text] [Related]
14. The role of concurrent chemotherapy for stage II nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A systematic review and meta-analysis.
Liu F; Jin T; Liu L; Xiang Z; Yan R; Yang H
PLoS One; 2018; 13(3):e0194733. PubMed ID: 29566078
[TBL] [Abstract][Full Text] [Related]
15. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X
Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847
[TBL] [Abstract][Full Text] [Related]
16. [Endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 71 patients and analysis of the prognostic factors].
Sun X; Liu J; Wang H; Yu H; Wang J; Li H; Gu Y; Guo L; Wang D
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Nov; 50(11):890-5. PubMed ID: 26887992
[TBL] [Abstract][Full Text] [Related]
17. PTPN12 Affects Nasopharyngeal Carcinoma Cell Proliferation and Migration Through Regulating EGFR.
Lin Q; Wang H; Lin X; Zhang W; Huang S; Zheng Y
Cancer Biother Radiopharm; 2018 Mar; 33(2):60-64. PubMed ID: 29634414
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of cyclo-oxygenase-2 predicts poor survival of patients with nasopharyngeal carcinoma: a meta-analysis.
Sim CC; Sim EU
J Laryngol Otol; 2020 Apr; 134(4):338-343. PubMed ID: 32172705
[TBL] [Abstract][Full Text] [Related]
19. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
Wang B; Gu Q; Li J
Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
Uribe P; Gonzalez S
Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
